Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regenxbio Inc. (RGNX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regenxbio Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1590877.
Total stock buying since 2015: $3,850,000.
Total stock sales since 2015: $96,318,700.
Total stock option exercises since 2015: $13,594,252.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 20,602 | $163,044 | 51,354 | $193,090 |
2024 | 0 | $0 | 198,726 | $3,223,285 | 245,335 | $1,199,020 |
2023 | 0 | $0 | 48,138 | $955,385 | 80,000 | $133,475 |
2022 | 0 | $0 | 28,878 | $967,578 | 29,900 | $25,415 |
2021 | 0 | $0 | 303,884 | $12,811,279 | 120,998 | $1,097,833 |
2020 | 0 | $0 | 283,502 | $13,127,335 | 167,311 | $1,534,207 |
2019 | 0 | $0 | 248,238 | $12,137,989 | 369,132 | $2,249,954 |
2018 | 0 | $0 | 683,586 | $39,224,436 | 861,584 | $5,746,581 |
2017 | 0 | $0 | 438,479 | $11,375,850 | 332,530 | $1,308,427 |
2016 | 0 | $0 | 206,752 | $2,332,519 | 125,000 | $106,250 |
2015 | 175,000 | $3,850,000 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-05 | 0 | $0 | 20,602 | $163,044 | 20,602 | $77,463 |
2025-03 | 0 | $0 | 0 | $0 | 30,752 | $115,627 |
2024-10 | 0 | $0 | 10,000 | $101,050 | 10,000 | $37,600 |
2024-08 | 0 | $0 | 10,200 | $146,384 | 46,416 | $114,193 |
2024-07 | 0 | $0 | 60,648 | $839,416 | 51,000 | $290,538 |
2024-05 | 0 | $0 | 15,000 | $237,225 | 15,000 | $56,400 |
2024-04 | 0 | $0 | 15,000 | $272,865 | 15,000 | $56,400 |
2024-03 | 0 | $0 | 27,878 | $693,165 | 47,919 | $418,289 |
2024-02 | 0 | $0 | 15,000 | $250,170 | 15,000 | $56,400 |
2024-01 | 0 | $0 | 45,000 | $683,010 | 45,000 | $169,200 |
2023-12 | 0 | $0 | 45,000 | $885,825 | 45,000 | $103,725 |
2023-05 | 0 | $0 | 0 | $0 | 35,000 | $29,750 |
2023-01 | 0 | $0 | 3,138 | $69,560 | 0 | $0 |
2022-08 | 0 | $0 | 22,480 | $769,616 | 0 | $0 |
2022-07 | 0 | $0 | 4,800 | $144,030 | 0 | $0 |
2022-01 | 0 | $0 | 1,598 | $53,932 | 29,900 | $25,415 |
2021-12 | 0 | $0 | 112,869 | $3,933,299 | 0 | $0 |
2021-11 | 0 | $0 | 1,500 | $60,000 | 1,500 | $5,640 |
2021-09 | 0 | $0 | 87,733 | $3,934,512 | 39,500 | $97,595 |
2021-07 | 0 | $0 | 0 | $0 | 10,000 | $8,500 |
2021-06 | 0 | $0 | 6,000 | $240,465 | 6,000 | $22,560 |
2021-02 | 0 | $0 | 16,001 | $744,068 | 16,001 | $193,612 |
2021-01 | 0 | $0 | 79,781 | $3,898,935 | 47,997 | $769,926 |
2020-12 | 0 | $0 | 92,500 | $4,126,398 | 30,500 | $25,925 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-12 | Mills Kenneth T. | Sale | 20,602 | 7.91 | 163,044 |
2025-05-12 | Mills Kenneth T. | Option Ex | 20,602 | 3.76 | 77,463 |
2025-03-27 | Mills Kenneth T. | Option Ex | 30,752 | 3.76 | 115,627 |
2024-10-01 | Karabelas Argeris N | Sale | 10,000 | 10.11 | 101,050 |
2024-10-01 | Karabelas Argeris N | Option Ex | 10,000 | 3.76 | 37,600 |
2024-08-08 | Mills Kenneth T. | Option Ex | 36,316 | .85 | 30,868 |
2024-08-01 | Simpson Curran (Chief Executive Officer) | Sale | 100 | 15.00 | 1,500 |
2024-08-01 | Karabelas Argeris N | Sale | 10,100 | 14.35 | 144,884 |
2024-08-01 | Karabelas Argeris N | Option Ex | 10,100 | 8.25 | 83,325 |
2024-07-29 | Simpson Curran (Chief Executive Officer) | Sale | 9,648 | 15.04 | 145,105 |
2024-07-29 | Karabelas Argeris N | Sale | 11,000 | 15.04 | 165,495 |
2024-07-29 | Karabelas Argeris N | Option Ex | 11,000 | 12.74 | 140,140 |
2024-07-25 | Mills Kenneth T. | Sale | 15,369 | 13.96 | 214,505 |
2024-07-25 | Mills Kenneth T. | Option Ex | 15,369 | 3.76 | 57,787 |
2024-07-24 | Mills Kenneth T. | Sale | 12,221 | 13.78 | 168,429 |
2024-07-24 | Mills Kenneth T. | Option Ex | 12,221 | 3.76 | 45,950 |
2024-07-17 | Mills Kenneth T. | Sale | 2,210 | 13.77 | 30,440 |
2024-07-17 | Mills Kenneth T. | Option Ex | 2,210 | 3.76 | 8,309 |
2024-07-16 | Mills Kenneth T. | Sale | 200 | 13.76 | 2,752 |
2024-07-16 | Mills Kenneth T. | Option Ex | 200 | 3.76 | 752 |
2024-07-01 | Karabelas Argeris N | Sale | 10,000 | 11.27 | 112,690 |
2024-07-01 | Karabelas Argeris N | Option Ex | 10,000 | 3.76 | 37,600 |
2024-05-14 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 15.81 | 237,225 |
2024-05-14 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | 3.76 | 56,400 |
2024-04-15 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 18.19 | 272,865 |
2024-04-15 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | 3.76 | 56,400 |
2024-03-19 | Vasista Vittal (Chief Financial Officer) | Option Ex | 20,041 | 3.76 | 75,354 |
2024-03-14 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 21.86 | 327,945 |
2024-03-14 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | 3.76 | 56,400 |
2024-03-05 | Pakola Steve (Chief Medical Officer) | Sale | 12,878 | 28.36 | 365,220 |
2024-03-05 | Pakola Steve (Chief Medical Officer) | Option Ex | 12,878 | 22.25 | 286,535 |
2024-02-14 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 16.68 | 250,170 |
2024-02-14 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | 3.76 | 56,400 |
2024-01-16 | Mills Kenneth T. (President and CEO) | Sale | 45,000 | 15.18 | 683,010 |
2024-01-16 | Mills Kenneth T. (President and CEO) | Option Ex | 45,000 | 3.76 | 169,200 |
2023-12-19 | Mills Kenneth T. (President and CEO) | Sale | 45,000 | 19.68 | 885,825 |
2023-12-19 | Mills Kenneth T. (President and CEO) | Option Ex | 45,000 | 2.31 | 103,725 |
2023-05-31 | Vasista Vittal (Chief Financial Officer) | Option Ex | 35,000 | .85 | 29,750 |
2023-01-03 | Pakola Steve (Chief Medical Officer) | Sale | 3,138 | 22.17 | 69,560 |
2022-08-30 | Vasista Vittal (Chief Financial Officer) | Sale | 2,400 | 30.24 | 72,573 |
2022-08-05 | Vasista Vittal (Chief Financial Officer) | Sale | 17,280 | 35.19 | 608,031 |
2022-08-04 | Vasista Vittal (Chief Financial Officer) | Sale | 400 | 35.00 | 14,000 |
2022-08-01 | Vasista Vittal (Chief Financial Officer) | Sale | 2,400 | 31.25 | 75,012 |
2022-07-14 | Vasista Vittal (Chief Financial Officer) | Sale | 468 | 30.00 | 14,040 |
2022-07-13 | Vasista Vittal (Chief Financial Officer) | Sale | 4,332 | 30.01 | 129,990 |
2022-01-20 | Vasista Vittal (Chief Financial Officer) | Option Ex | 29,900 | .85 | 25,415 |
2022-01-03 | Pakola Steve (Chief Medical Officer) | Sale | 1,598 | 33.75 | 53,932 |
2021-12-23 | Fox Allan M. | Sale | 51,231 | 35.38 | 1,812,706 |
2021-12-22 | Fox Allan M. | Sale | 61,638 | 34.40 | 2,120,593 |
2021-11-08 | Mills Kenneth T. (President and CEO) | Sale | 1,500 | 40.00 | 60,000 |
2021-11-08 | Mills Kenneth T. (President and CEO) | Option Ex | 1,500 | 3.76 | 5,640 |
2021-09-27 | Mills Kenneth T. (President and CEO) | Sale | 1,500 | 42.19 | 63,285 |
2021-09-27 | Mills Kenneth T. (President and CEO) | Option Ex | 1,500 | 3.76 | 5,640 |
2021-09-17 | Fox Allan M. (Director) | Sale | 48,233 | 45.04 | 2,172,317 |
2021-09-14 | Mills Kenneth T. (President and CEO) | Sale | 35,000 | 45.11 | 1,578,850 |
2021-09-14 | Mills Kenneth T. (President and CEO) | Option Ex | 35,000 | 2.31 | 80,675 |
2021-09-13 | Mills Kenneth T. (President and CEO) | Sale | 3,000 | 40.02 | 120,060 |
2021-09-13 | Mills Kenneth T. (President and CEO) | Option Ex | 3,000 | 3.76 | 11,280 |
2021-07-27 | Vasista Vittal (Chief Financial Officer) | Option Ex | 10,000 | .85 | 8,500 |
2021-06-25 | Mills Kenneth T. (President and CEO) | Sale | 1,500 | 40.25 | 60,375 |
2021-06-25 | Mills Kenneth T. (President and CEO) | Option Ex | 1,500 | 3.76 | 5,640 |
2021-06-24 | Mills Kenneth T. (President and CEO) | Sale | 4,500 | 40.02 | 180,090 |
2021-06-24 | Mills Kenneth T. (President and CEO) | Option Ex | 4,500 | 3.76 | 16,920 |
2021-02-12 | Christmas Patrick J. (Chief Legal Officer) | Sale | 4,701 | 49.08 | 230,725 |
2021-02-12 | Christmas Patrick J. (Chief Legal Officer) | Option Ex | 4,701 | 12.10 | 56,882 |
2021-02-08 | Christmas Patrick J. (Chief Legal Officer) | Sale | 1,300 | 49.11 | 63,843 |
2021-02-08 | Christmas Patrick J. (Chief Legal Officer) | Option Ex | 1,300 | 12.10 | 15,730 |
2021-02-02 | Christmas Patrick J. (Chief Legal Officer) | Sale | 10,000 | 44.95 | 449,500 |
2021-02-02 | Christmas Patrick J. (Chief Legal Officer) | Option Ex | 10,000 | 12.10 | 121,000 |
2021-01-25 | Mills Kenneth T. (President and CEO) | Sale | 6,500 | 43.89 | 285,304 |
2021-01-25 | Mills Kenneth T. (President and CEO) | Option Ex | 6,500 | .85 | 5,525 |
2021-01-15 | Vasista Vittal (Chief Financial Officer) | Sale | 252 | 50.04 | 12,610 |
2021-01-14 | Vasista Vittal (Chief Financial Officer) | Sale | 11,093 | 50.03 | 554,982 |
2021-01-14 | Simpson Curran (Chief Oper. & Tech. Officer) | Sale | 11,612 | 50.01 | 580,716 |
2021-01-14 | Simpson Curran (Chief Oper. & Tech. Officer) | Option Ex | 11,612 | 27.65 | 321,071 |
2021-01-12 | Vasista Vittal (Chief Financial Officer) | Sale | 4,200 | 50.01 | 210,042 |
2021-01-12 | Christmas Patrick J. (Chief Legal Officer) | Sale | 1,378 | 49.15 | 67,728 |
2021-01-12 | Christmas Patrick J. (Chief Legal Officer) | Option Ex | 1,378 | 19.50 | 26,871 |
2021-01-12 | Simpson Curran (Chief Oper. & Tech. Officer) | Sale | 1,700 | 50.03 | 85,051 |
2021-01-12 | Simpson Curran (Chief Oper. & Tech. Officer) | Option Ex | 1,700 | 19.50 | 33,150 |
2021-01-11 | Christmas Patrick J. (Chief Legal Officer) | Sale | 10,122 | 49.08 | 496,787 |
2021-01-11 | Christmas Patrick J. (Chief Legal Officer) | Option Ex | 10,122 | 15.80 | 159,927 |
2021-01-08 | Vasista Vittal (Chief Financial Officer) | Sale | 5,241 | 47.36 | 248,229 |
2021-01-08 | Christmas Patrick J. (Chief Legal Officer) | Sale | 10,000 | 47.33 | 473,270 |
2021-01-08 | Christmas Patrick J. (Chief Legal Officer) | Option Ex | 10,000 | 12.10 | 121,000 |
2021-01-07 | Vasista Vittal (Chief Financial Officer) | Sale | 10,998 | 50.00 | 549,900 |
2021-01-07 | Mills Kenneth T. (President and CEO) | Sale | 1,500 | 50.01 | 75,015 |
2021-01-07 | Mills Kenneth T. (President and CEO) | Option Ex | 1,500 | .85 | 1,275 |
2021-01-07 | Simpson Curran (Chief Oper. & Tech. Officer) | Sale | 5,185 | 50.01 | 259,301 |
2021-01-07 | Simpson Curran (Chief Oper. & Tech. Officer) | Option Ex | 5,185 | 19.50 | 101,107 |
2020-12-28 | Mills Kenneth T. (President and CEO) | Sale | 6,500 | 48.81 | 317,297 |
2020-12-28 | Mills Kenneth T. (President and CEO) | Option Ex | 6,500 | .85 | 5,525 |
2020-12-24 | Vasista Vittal (Chief Financial Officer) | Sale | 3,376 | 50.00 | 168,800 |
2020-12-23 | Vasista Vittal (Chief Financial Officer) | Sale | 21,124 | 50.01 | 1,056,411 |
2020-12-23 | Mills Kenneth T. (President and CEO) | Sale | 4,500 | 50.00 | 225,000 |
2020-12-23 | Mills Kenneth T. (President and CEO) | Option Ex | 4,500 | .85 | 3,825 |
2020-12-16 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 45.00 | 675,000 |
2020-12-16 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | .85 | 12,750 |
2020-12-11 | Vasista Vittal (Chief Financial Officer) | Sale | 14,916 | 40.17 | 599,175 |
2020-12-10 | Vasista Vittal (Chief Financial Officer) | Sale | 22,584 | 40.06 | 904,715 |
2020-12-10 | Mills Kenneth T. (President and CEO) | Sale | 4,500 | 40.00 | 180,000 |
2020-12-10 | Mills Kenneth T. (President and CEO) | Option Ex | 4,500 | .85 | 3,825 |
2020-07-15 | Vasista Vittal (Chief Financial Officer) | Sale | 14,950 | 40.10 | 599,495 |
2020-07-15 | Vasista Vittal (Chief Financial Officer) | Option Ex | 3,259 | 13.09 | 42,660 |
2020-05-11 | Vasista Vittal (Chief Financial Officer) | Sale | 500 | 40.00 | 20,000 |
2020-05-11 | Vasista Vittal (Chief Financial Officer) | Option Ex | 500 | 13.09 | 6,545 |
2020-05-08 | Vasista Vittal (Chief Financial Officer) | Sale | 7,000 | 40.18 | 281,260 |
2020-05-08 | Vasista Vittal (Chief Financial Officer) | Option Ex | 2,500 | 13.09 | 32,725 |
2020-04-24 | Vasista Vittal (Chief Financial Officer) | Sale | 12,000 | 40.11 | 481,320 |
2020-04-24 | Vasista Vittal (Chief Financial Officer) | Option Ex | 3,000 | 13.09 | 39,270 |
2020-04-23 | Vasista Vittal (Chief Financial Officer) | Sale | 3,000 | 40.00 | 120,000 |
2020-04-23 | Vasista Vittal (Chief Financial Officer) | Option Ex | 3,000 | 13.09 | 39,270 |
2020-03-31 | Vasista Vittal (Chief Financial Officer) | Option Ex | 10,000 | .85 | 8,500 |
2020-02-11 | Simpson Curran (SVP, Product Development & CTO) | Sale | 12,564 | 50.75 | 637,623 |
2020-02-11 | Simpson Curran (SVP, Product Development & CTO) | Option Ex | 6,633 | 22.00 | 145,926 |
2020-02-10 | Vasista Vittal (Chief Financial Officer) | Sale | 14,806 | 49.59 | 734,155 |
2020-02-10 | Vasista Vittal (Chief Financial Officer) | Option Ex | 3,000 | 13.09 | 39,270 |
2020-02-10 | Simpson Curran (SVP, Product Development & CTO) | Sale | 44,429 | 50.22 | 2,231,224 |
2020-02-10 | Simpson Curran (SVP, Product Development & CTO) | Option Ex | 31,660 | 25.77 | 815,783 |
2020-02-10 | Hayden Donald J Jr | Sale | 24,800 | 50.11 | 1,242,728 |
2020-02-10 | Hayden Donald J Jr | Option Ex | 24,800 | .85 | 21,080 |
2020-02-05 | Vasista Vittal (Chief Financial Officer) | Sale | 300 | 50.00 | 15,000 |
2020-02-05 | Simpson Curran (SVP, Product Development & CTO) | Sale | 5,637 | 50.00 | 281,850 |
2020-02-05 | Simpson Curran (SVP, Product Development & CTO) | Option Ex | 5,137 | 22.60 | 116,085 |
2020-02-05 | Hayden Donald J Jr | Sale | 2,000 | 50.00 | 100,000 |
2020-02-05 | Hayden Donald J Jr | Option Ex | 2,000 | .85 | 1,700 |
2020-01-17 | Vasista Vittal (Chief Financial Officer) | Sale | 2,394 | 50.00 | 119,700 |
2020-01-17 | Simpson Curran (SVP, Product Development & CTO) | Sale | 5,922 | 50.00 | 296,100 |
2020-01-17 | Simpson Curran (SVP, Product Development & CTO) | Option Ex | 5,122 | 25.77 | 131,978 |
2020-01-17 | Hayden Donald J Jr | Sale | 3,200 | 50.01 | 160,032 |
2020-01-17 | Hayden Donald J Jr | Option Ex | 3,200 | .85 | 2,720 |
2020-01-14 | Hayden Donald J Jr | Sale | 30,000 | 45.60 | 1,368,000 |
2020-01-14 | Hayden Donald J Jr | Option Ex | 30,000 | .85 | 25,500 |
2020-01-08 | Vasista Vittal (Chief Financial Officer) | Sale | 7,500 | 41.66 | 312,450 |
2020-01-08 | Vasista Vittal (Chief Financial Officer) | Option Ex | 3,000 | 13.09 | 39,270 |
2019-12-09 | Simpson Curran (SVP, Product Development & CTO) | Sale | 15,552 | 43.83 | 681,644 |
2019-09-19 | Mills Kenneth T. (President and CEO) | Sale | 10,000 | 39.55 | 395,500 |
2019-09-19 | Mills Kenneth T. (President and CEO) | Option Ex | 5,000 | .85 | 4,250 |
2019-09-12 | Christmas Patrick J. (SVP, General Counsel) | Sale | 5,486 | 42.00 | 230,412 |
2019-09-12 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 5,000 | 12.10 | 60,500 |
2019-08-19 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 37.73 | 565,950 |
2019-08-19 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | .85 | 12,750 |
2019-07-19 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 49.69 | 745,275 |
2019-07-19 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | .85 | 12,750 |
2019-07-19 | Christmas Patrick J. (SVP, General Counsel) | Sale | 4,900 | 50.03 | 245,147 |
2019-07-19 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 4,900 | 19.50 | 95,550 |
2019-07-18 | Christmas Patrick J. (SVP, General Counsel) | Sale | 100 | 50.00 | 5,000 |
2019-07-18 | Christmas Patrick J. (SVP, General Counsel) | Option Ex | 100 | 19.50 | 1,950 |
2019-06-19 | Mills Kenneth T. (President and CEO) | Sale | 15,000 | 52.76 | 791,400 |
2019-06-19 | Mills Kenneth T. (President and CEO) | Option Ex | 15,000 | .85 | 12,750 |
Insider trading activities including stock purchases, stock sales, and option exercises of RGNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regenxbio Inc. (symbol RGNX, CIK number 1590877) see the Securities and Exchange Commission (SEC) website.